
Michael Michelakis, MD
Psychiatry in Grand Rapids, MI
- Public record — not managed by the clinician
About Dr. Michael Michelakis
Dr. Michael Michelakis is a physician specializing in psychiatry practicing in Grand Rapids, MI. Records list 2 practice addresses. Treated 53 Medicare patients in 2024.
Provider details
| Specialty | PsychiatryOther psychiatry doctors in Grand Rapids |
|---|---|
| Credentials | MD |
| Gender | Male |
| NPI number | 1235176249National Provider Identifier (CMS NPPES), issued May 2006 |
Dr. Michael Michelakis' specialties and state licenses
- Psychiatry Primary
License: MI 4301060055
As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.
Where Dr. Michael Michelakis practices
Addresses from the NPPES NPI registry. Call before visiting: a clinician may not see patients at every listed address.
Dr. Michael Michelakis' Medicare patients and services (2024)
Most frequent services
| Service | Times | Avg. Medicare allowed |
|---|---|---|
| Injection of drug or substance under skin or into muscle | 189 | $13.43 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 36 | $121.40 |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 34 | $170.79 |
Common conditions among these patients
Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.
Payments from drug and device companies to Dr. Michael Michelakis (2025)
$510.07 in 13 general payments reported in 2025.
| Type | Payments | Amount |
|---|---|---|
| Food and beverage | 12 | $437.57 |
| Education | 1 | $72.50 |
Paying companies: Otsuka America Pharmaceutical, Inc. ($170.29), Neurocrine Biosciences, Inc. ($73.21), Teva Pharmaceuticals USA, Inc. ($72.50), Vanda Pharmaceuticals Inc. ($50.91), AbbVie Inc. ($35.88), Axsome Therapeutics, Inc. ($32.27).
Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.
Questions about Dr. Michael Michelakis
What kind of clinician is Dr. Michael Michelakis?
Dr. Michael Michelakis is listed as a physician specializing in psychiatry.
Where does Dr. Michael Michelakis practice?
The main practice address at 300 68th St SE, Grand Rapids, MI 49548, and 1 other address in the records.
What is the office phone number for Dr. Michael Michelakis?
The listed office number is (616) 455-5000. Call to confirm availability and whether new patients are accepted.
What is the NPI number of Dr. Michael Michelakis?
The National Provider Identifier is 1235176249.
Where this information comes from
| NPPES NPI registry | NPI, specialties (taxonomy) and state licenses, name and practice addresses.CMS National Plan and Provider Enumeration System; record updated 2025-03-26 |
|---|---|
| Medicare utilization | Patients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024 |
| Open Payments | Payments from drug and device companies.CMS Open Payments, program year 2025 |
Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.
Need an appointment?
Call the office at (616) 455-5000 to check availability.